Literature DB >> 25840771

The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins.

Nobuki Matsuyama1, Kazuta Yasui, Etsuko Amakishi, Tomoya Hayashi, Ayumu Kuroishi, Hiroyuki Ishii, Harumichi Matsukura, Yoshihiko Tani, Rika A Furuta, Fumiya Hirayama.   

Abstract

On transfusion, several plasma proteins can cause anaphylaxis in patients deficient in the corresponding plasma proteins. However, little is known about other allergens, which are encountered much more infrequently. Although it has been speculated that an allergen-independent pathway underlying allergic transfusion reactions (ATRs) is elicited by biological response modifiers accumulated in blood components during storage, the exact mechanisms remain unresolved. Furthermore, it is difficult even to determine whether ATRs are induced via allergen-dependent or allergen-independent pathways. To distinguish these two pathways in ATR cases, we established a basophil activation test, in which the basophil-activating ability of supernatants of residual transfused blood of ATR cases to whole blood basophils was assessed in the presence or absence of dasatinib, an inhibitor of IgE-mediated basophil activation. Three of 37 supernatants from the platelet concentrates with ATRs activated panel blood basophils in the absence, but not in the presence, of dasatinib. The basophil activation was inhibited by treatment of anti-fish collagen I MoAb in one case, suggesting that the involvement of fish allergens may have been present in donor plasma. We concluded that unknown non-plasma proteins, some of which had epitopes similar to fish antigens, in blood component may be involved in ATRs via an allergen/IgE-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840771     DOI: 10.1007/s12185-015-1794-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  39 in total

1.  Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

Authors:  Louis J Lombardo; Francis Y Lee; Ping Chen; Derek Norris; Joel C Barrish; Kamelia Behnia; Stephen Castaneda; Lyndon A M Cornelius; Jagabandhu Das; Arthur M Doweyko; Craig Fairchild; John T Hunt; Ivan Inigo; Kathy Johnston; Amrita Kamath; David Kan; Herbert Klei; Punit Marathe; Suhong Pang; Russell Peterson; Sidney Pitt; Gary L Schieven; Robert J Schmidt; John Tokarski; Mei-Li Wen; John Wityak; Robert M Borzilleri
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

Review 2.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Authors:  Terrence L Geiger; Scott C Howard
Journal:  Transfus Med Rev       Date:  2007-01

3.  Application of the basophil activation test in the analysis of allergic transfusion reactions.

Authors:  N Matsuyama; F Hirayama; S Wakamoto; K Yasui; R A Furuta; T Kimura; A Taniue; Y Fukumori; M Fujihara; H Azuma; H Ikeda; Y Tani; H Shibata
Journal:  Transfus Med       Date:  2009-10       Impact factor: 2.019

Review 4.  The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based.

Authors:  S Gerald Sandler; Anne F Eder; Mindy Goldman; Jeffrey L Winters
Journal:  Transfusion       Date:  2014-07-28       Impact factor: 3.157

5.  Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity.

Authors:  P Lambin; P Y Le Pennec; G Hauptmann; O Desaint; B Habibi; C Salmon
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

Review 6.  Platelets and cytokines: How and why?

Authors:  O Garraud; H Hamzeh-Cognasse; F Cognasse
Journal:  Transfus Clin Biol       Date:  2012-06-07       Impact factor: 1.406

Review 7.  BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia.

Authors:  Sheila A Doggrell
Journal:  Expert Opin Investig Drugs       Date:  2005-01       Impact factor: 6.206

8.  Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies.

Authors:  Eiko Shimada; Kenji Tadokoro; Yoshihisa Watanabe; Kazuyo Ikeda; Hiromi Niihara; Ikiko Maeda; Kazumi Isa; Susumu Moriya; Takashi Ashida; Shigeki Mitsunaga; Kazunori Nakajima; Takeo Juji
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

9.  Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases.

Authors:  E Eiseman; J B Bolen
Journal:  Nature       Date:  1992-01-02       Impact factor: 49.962

10.  Allergic transfusion reactions: an evaluation of 273 consecutive reactions.

Authors:  Ronald E Domen; Gerald A Hoeltge
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

View more
  1 in total

1.  Perceptions About Blood Transfusion Therapy Among the General Public and Healthcare Professionals in the Qassim Region of Saudi Arabia.

Authors:  Ashwag S Alsharidah; Haifa A Alsuhaibani; Basma S Almansour; Mansour S Alsharidah
Journal:  J Blood Med       Date:  2021-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.